Filing Details
- Accession Number:
- 0001127602-10-004204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-10 12:00:00
- Reporting Period:
- 2010-02-08
- Filing Date:
- 2010-02-10
- Accepted Time:
- 2010-02-10 17:50:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1097264 | Allos Therapeutics Inc | ALTH | Pharmaceutical Preparations (2834) | 541655029 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202769 | L Paul Berns | 11080 Circlepoint Road Suite 200 Westminster CO 80020 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-02-08 | 32,580 | $7.00 | 134,167 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Berns sold a portion of his holdings for tax and estate planning purposes.
- The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $7.00 to $7.01. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.